Back to resultsEfficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Primary Purpose
Chronic Lymphocytic Leukemia
Status
Unknown status
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Nipent, Cytoxan, Rituxan
Sponsored by
About this trial
This is an interventional treatment trial for Chronic Lymphocytic Leukemia focused on measuring Leukemia, Cancer, Nipent, Rituxan, Cytoxan
Eligibility Criteria
Inclusion Criteria: Stage II, III or IV Chronic Lymphocytic Leukemia Disease requires chemotherapeutic treatment CT or MRI scan confirming measurable tumor size Documentation of CD markers Up to one prior treatment regimen Expected survival greater than 6 months ECOG performance status of 0-2 Adequate renal, bone marrow and liver functions Negative pregnancy test (females of childbearing potential) Must agree to use acceptable birth control, if fertile Must complete Informed Consent No heart disease and must have adequate cardiac function Must test negative for viral Hepatitis B and C Exclusion Criteria: More than one prior treatment for Chronic Lymphocytic Leukemia Known sensitivity to Nipent, Rituxan or Cytoxan or any component of these drugs Known HIV or AIDS illness Thyroid disease requiring medication History of any malignancy that could affect the diagnosis or assessment of the study treatment Pregnancy or breast feeding Evidence of Hepatitis B or C infection Inability to comply with the requirements of the study
Sites / Locations
- Northwest Alabama Cancer Center, PCRecruiting
- East Valley Hematology and Oncology Medical GroupRecruiting
- Bay Area Cancer Research GroupRecruiting
- Lalita Pandit, MD, Inc.Recruiting
- Pacific Coast Hematology/Oncology Medical Group, Inc.Recruiting
- Robert A. Moss, M.D. FACP, Inc.Recruiting
- Metropolitan Hematology Oncology Medical GroupRecruiting
- North County OncologyRecruiting
- Ventura County Hematology Oncology SpecialistsRecruiting
- Cancer and Blood Institute Medical GroupRecruiting
- St. Teresa Comprehensive Cancer CenterRecruiting
- Medical Group of North CountyRecruiting
- The Oncology Clinic, PCRecruiting
- Mile High OncologyRecruiting
- Palm Beach Institute of Hematology and OncologyRecruiting
- Integrated Community Oncology NetworkRecruiting
- Osceola Cancer CenterRecruiting
- Pasco Hernando Oncology Associates, PARecruiting
- Pasco Pinellas Cancer CenterRecruiting
- Augusta Oncology Associates, PCRecruiting
- Spalding Oncology ServicesRecruiting
- St Luke's Mountain States Tumor InstituteRecruiting
- Oncology Hematology Assoc. of Northern IllinoisRecruiting
- Indiana Oncology Hematology ConsultantsRecruiting
- Arnett Cancer CareRecruiting
- Cancer Care CenterRecruiting
- Kentucky Cancer ClinicRecruiting
- Greater Baltimore Medical CenterRecruiting
- Chesapeake Oncology Hematology AssociatesRecruiting
- Auerbach Hematology Oncology Associates, Inc.Recruiting
- Genesee Cancer & Blood Disease Treatment Center, PCRecruiting
- West Michigan Regional Cancer & Blood CenterRecruiting
- Spectrum Health HospitalsRecruiting
- Branson Oncology ClinicRecruiting
- St. Louis Hematology Oncology Specialists, Inc.Recruiting
- Sierra Nevada Oncology CareRecruiting
- Nevada Cancer CenterRecruiting
- The Center for Cancer and Hematologic DiseaseRecruiting
- Ellioth Fishkin, MDRecruiting
- Westchester Hematology Oncology AssociatesRecruiting
- Mid Dakota Clinic/Odyssey ResearchRecruiting
- Summa Health System HospitalsRecruiting
- Nashat Y. Gabrail, MD, Inc.Recruiting
- Sambandam and Joseph Associates, IncRecruiting
- Charleston Hematology Oncology, PARecruiting
- South Carolina Oncology AssociatesRecruiting
- The Family Cancer CenterRecruiting
- C. Michael Jones, MD, PCRecruiting
- JPS Center for Cancer CareRecruiting
- Cache Valley Cancer Treatment & Research Clinic, Inc.Recruiting
- Cancer Outreach Associates, PCRecruiting
- Virginia Oncology Care, PCRecruiting
Outcomes
Primary Outcome Measures
Efficacy response rate
Secondary Outcome Measures
Time to progression
Time to treatment failure
Toxicity
Incidence and severity of adverse events
Full Information
NCT ID
NCT00131313
First Posted
August 16, 2005
Last Updated
August 17, 2005
Sponsor
East Valley Hematology and Oncology Medical Group
Collaborators
Mena, Raul, M.D., Pharmatech Oncology, Astex Pharmaceuticals, Inc.
1. Study Identification
Unique Protocol Identification Number
NCT00131313
Brief Title
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Official Title
A Multicenter, Open-Label Study of Nipent, Cytoxan and Rituxan in Patients With Previously Untreated or Treated Chronic Lymphocytic Leukemia.
Study Type
Interventional
2. Study Status
Record Verification Date
August 2005
Overall Recruitment Status
Unknown status
Study Start Date
January 2003 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
April 2009 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
East Valley Hematology and Oncology Medical Group
Collaborators
Mena, Raul, M.D., Pharmatech Oncology, Astex Pharmaceuticals, Inc.
4. Oversight
5. Study Description
Brief Summary
This research study measures the safety and efficacy of the combination of three drugs that are approved, Nipent, Rituxan and Cytoxan in the treatment of Chronic Lymphocytic Leukemia (CLL). These drugs are being given together for investigational purposes as the specific combination of these three drugs has not been approved for treatment of CLL by the FDA.
Detailed Description
Chronic Lymphocytic Leukemia (CLL) is the most common form of adult leukemia in the U.S. Recent experience with Nipent in conjunction with Rituxan has shown that this combination is well tolerated and is clinically promising. It is expected that the addition of Cytoxan in patients with previously untreated CLL and patients who have relapsed or failed prior therapy may benefit from combined therapy using Nipent, Cytoxan and Rituxan. It is unknown how the addition of Cytoxan will affect the toxicity profile of the Rituxan and Nipent regimen, however, patients will be monitored for toxicities. It is expected that bone marrow toxicities will not increase to unreasonable levels.
The primary objective of the study is to determine the overall efficacy response rate following treatment with Nipent, Cytoxan and Rituxan of patients with previously untreated or treated CLL. The secondary objectives of the study are to determine the duration of response, time to progression, time to treatment failure and to evaluate the toxicity of this combination of drugs and the incidence and severity of adverse events.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Lymphocytic Leukemia
Keywords
Leukemia, Cancer, Nipent, Rituxan, Cytoxan
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
180 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Nipent, Cytoxan, Rituxan
Primary Outcome Measure Information:
Title
Efficacy response rate
Secondary Outcome Measure Information:
Title
Time to progression
Title
Time to treatment failure
Title
Toxicity
Title
Incidence and severity of adverse events
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Stage II, III or IV Chronic Lymphocytic Leukemia
Disease requires chemotherapeutic treatment
CT or MRI scan confirming measurable tumor size
Documentation of CD markers
Up to one prior treatment regimen
Expected survival greater than 6 months
ECOG performance status of 0-2
Adequate renal, bone marrow and liver functions
Negative pregnancy test (females of childbearing potential)
Must agree to use acceptable birth control, if fertile
Must complete Informed Consent
No heart disease and must have adequate cardiac function
Must test negative for viral Hepatitis B and C
Exclusion Criteria:
More than one prior treatment for Chronic Lymphocytic Leukemia
Known sensitivity to Nipent, Rituxan or Cytoxan or any component of these drugs
Known HIV or AIDS illness
Thyroid disease requiring medication
History of any malignancy that could affect the diagnosis or assessment of the study treatment
Pregnancy or breast feeding
Evidence of Hepatitis B or C infection
Inability to comply with the requirements of the study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Tracy Latimer
Phone
720-917-7478
Email
tracyl@pharmatech.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Raul Mena, MD
Organizational Affiliation
East Valley Hematology and Oncology Group
Official's Role
Principal Investigator
Facility Information:
Facility Name
Northwest Alabama Cancer Center, PC
City
Muscle Shoals
State/Province
Alabama
ZIP/Postal Code
35661
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
James Daugherty, MD
First Name & Middle Initial & Last Name & Degree
James Daugherty, MD
Facility Name
East Valley Hematology and Oncology Medical Group
City
Burbank
State/Province
California
ZIP/Postal Code
91505
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Raul R Mena, MD
First Name & Middle Initial & Last Name & Degree
Raul R Mena, MD
Facility Name
Bay Area Cancer Research Group
City
Concord
State/Province
California
ZIP/Postal Code
94520
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Robert L Robles, MD
First Name & Middle Initial & Last Name & Degree
Robert L Robles, MD
Facility Name
Lalita Pandit, MD, Inc.
City
Fountain Valley
State/Province
California
ZIP/Postal Code
92708
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lalita Pandit, MD
First Name & Middle Initial & Last Name & Degree
Lalita Pandit, MD
Facility Name
Pacific Coast Hematology/Oncology Medical Group, Inc.
City
Fountain Valley
State/Province
California
ZIP/Postal Code
92708
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Glen R Justice, MD
First Name & Middle Initial & Last Name & Degree
Glen R Justice, MD
Facility Name
Robert A. Moss, M.D. FACP, Inc.
City
Fountain Valley
State/Province
California
ZIP/Postal Code
92708
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Robert A Moss, MD, FACP
First Name & Middle Initial & Last Name & Degree
Robert A Moss, MD, FACP
Facility Name
Metropolitan Hematology Oncology Medical Group
City
Los Angeles
State/Province
California
ZIP/Postal Code
90057
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Peter S Kennedy, MD
First Name & Middle Initial & Last Name & Degree
Peter S Kennedy, MD
Facility Name
North County Oncology
City
Oceanside
State/Province
California
ZIP/Postal Code
92056
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Warren S Paroly, MD
First Name & Middle Initial & Last Name & Degree
Warren S Paroly, MD
Facility Name
Ventura County Hematology Oncology Specialists
City
Oxnard
State/Province
California
ZIP/Postal Code
93030
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rosemary E McIntyre, MD,PharmD
First Name & Middle Initial & Last Name & Degree
Rosemary E McIntyre, MD,PharmD
Facility Name
Cancer and Blood Institute Medical Group
City
Rancho Mirage
State/Province
California
ZIP/Postal Code
92270
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Robert H Lemon, MD
First Name & Middle Initial & Last Name & Degree
Robert H Lemon, MD
Facility Name
St. Teresa Comprehensive Cancer Center
City
Stockton
State/Province
California
ZIP/Postal Code
95207
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Neelesh S Bangalore, MD, PhD
First Name & Middle Initial & Last Name & Degree
Neelesh S Bangalore, MD, PhD
Facility Name
Medical Group of North County
City
Vista
State/Province
California
ZIP/Postal Code
92081
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alberto Bessudo, MD
First Name & Middle Initial & Last Name & Degree
Alberto Bessudo, MD
Facility Name
The Oncology Clinic, PC
City
Colorado Springs
State/Province
Colorado
ZIP/Postal Code
80907
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
David Headley, DO
First Name & Middle Initial & Last Name & Degree
David Headley, DO
Facility Name
Mile High Oncology
City
Denver
State/Province
Colorado
ZIP/Postal Code
80210
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
David Schrier, MD, DO
First Name & Middle Initial & Last Name & Degree
David Schrier, MD, DO
Facility Name
Palm Beach Institute of Hematology and Oncology
City
Boynton Beach
State/Province
Florida
ZIP/Postal Code
33435
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eyal Meiri, MD
First Name & Middle Initial & Last Name & Degree
Eyal Meiri, MD
Facility Name
Integrated Community Oncology Network
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32256
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Medhi M Moezi, MD
First Name & Middle Initial & Last Name & Degree
Medhi M Moezi, MD
Facility Name
Osceola Cancer Center
City
Kissimmee
State/Province
Florida
ZIP/Postal Code
34741
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jorge G Otoya, MD
First Name & Middle Initial & Last Name & Degree
Jorge G Otoya, MD
Facility Name
Pasco Hernando Oncology Associates, PA
City
New Port Richey
State/Province
Florida
ZIP/Postal Code
34642
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
K.S. Kumar, MD
First Name & Middle Initial & Last Name & Degree
K.S. Kumar, MD
Facility Name
Pasco Pinellas Cancer Center
City
New Port Richey
State/Province
Florida
ZIP/Postal Code
34652
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Roberto Arevalo-Araujo, MD,PharmD,PA
First Name & Middle Initial & Last Name & Degree
Roberto Arevalo-Araujo, MD,PharmD,PA
Facility Name
Augusta Oncology Associates, PC
City
Augusta
State/Province
Georgia
ZIP/Postal Code
30901
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mark R Keaton, MD
First Name & Middle Initial & Last Name & Degree
Mark R Keaton, MD
Facility Name
Spalding Oncology Services
City
Griffin
State/Province
Georgia
ZIP/Postal Code
30224
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rao Moravineni, MD
First Name & Middle Initial & Last Name & Degree
Rao Moravineni, MD
Facility Name
St Luke's Mountain States Tumor Institute
City
Boise
State/Province
Idaho
ZIP/Postal Code
83712
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Theodore Walters, MD
First Name & Middle Initial & Last Name & Degree
Theodore Walters, MD
Facility Name
Oncology Hematology Assoc. of Northern Illinois
City
Gurnee
State/Province
Illinois
ZIP/Postal Code
60031
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nilesh D Mehta, MD, FACP
First Name & Middle Initial & Last Name & Degree
Nilesh D Mehta, MD, FACP
Facility Name
Indiana Oncology Hematology Consultants
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46202
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maureen Cooper, MD
First Name & Middle Initial & Last Name & Degree
Maureen Cooper, MD
Facility Name
Arnett Cancer Care
City
Lafayette
State/Province
Indiana
ZIP/Postal Code
47904
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Thomas I Jones, MD
First Name & Middle Initial & Last Name & Degree
Thomas I Jones, MD
Facility Name
Cancer Care Center
City
New Albany
State/Province
Indiana
ZIP/Postal Code
47150
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Naveed Chowhan, MD
First Name & Middle Initial & Last Name & Degree
Naveed Chowhan, MD
Facility Name
Kentucky Cancer Clinic
City
Hazard
State/Province
Kentucky
ZIP/Postal Code
41701
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hassan Ghazal, MD
First Name & Middle Initial & Last Name & Degree
Hassan Ghazal, MD
Facility Name
Greater Baltimore Medical Center
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21204
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Madhu Chaudhry, MD, MBBS
First Name & Middle Initial & Last Name & Degree
Madhu Chaudry, MD, MBBS
Facility Name
Chesapeake Oncology Hematology Associates
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21225
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yudhishtra Markan, MD
First Name & Middle Initial & Last Name & Degree
Yudhishtra Markan, MD
Facility Name
Auerbach Hematology Oncology Associates, Inc.
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21237
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michael Auerbach, MD, PharmD,FACP
First Name & Middle Initial & Last Name & Degree
Michael Auerbach, MD, PharmD,FACP
Facility Name
Genesee Cancer & Blood Disease Treatment Center, PC
City
Flint
State/Province
Michigan
ZIP/Postal Code
48503
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rizwan Danish, MD, FACP
First Name & Middle Initial & Last Name & Degree
Rizwan Danish, MD, FACP
Facility Name
West Michigan Regional Cancer & Blood Center
City
Freesoil
State/Province
Michigan
ZIP/Postal Code
49411
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ahmed S Behairy, MD
First Name & Middle Initial & Last Name & Degree
Ahmed S Behairy, MD
Facility Name
Spectrum Health Hospitals
City
Grand Rapids
State/Province
Michigan
ZIP/Postal Code
49503
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Timothy O'Rourke, MD
First Name & Middle Initial & Last Name & Degree
Timothy O'Rourke, MD
Facility Name
Branson Oncology Clinic
City
Branson
State/Province
Missouri
ZIP/Postal Code
65616
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pairote Jaroonwanichkul, MD
First Name & Middle Initial & Last Name & Degree
Pairote Jaroonwanichkul, MD
Facility Name
St. Louis Hematology Oncology Specialists, Inc.
City
St. Louis
State/Province
Missouri
ZIP/Postal Code
63117
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alvin Schergen, MD, PharmD,FACP
First Name & Middle Initial & Last Name & Degree
Alvin Schergen, MD, PharmD,FACP
Facility Name
Sierra Nevada Oncology Care
City
Carson City
State/Province
Nevada
ZIP/Postal Code
89703
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jorge Perez-Cardona, MD
First Name & Middle Initial & Last Name & Degree
Jorge Perez-Cardona, MD
Facility Name
Nevada Cancer Center
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89109
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
M. Nafees Nagy, MD
First Name & Middle Initial & Last Name & Degree
M. Nafees Nagy, MD
Facility Name
The Center for Cancer and Hematologic Disease
City
Cherry Hill
State/Province
New Jersey
ZIP/Postal Code
08003
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Stephen Zrada, MD
First Name & Middle Initial & Last Name & Degree
Stephen Zrada, MD
Facility Name
Ellioth Fishkin, MD
City
Elizabeth
State/Province
New Jersey
ZIP/Postal Code
07201
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ellioth Fishkin, MD
First Name & Middle Initial & Last Name & Degree
Ellioth Fishkin, MD
Facility Name
Westchester Hematology Oncology Associates
City
Mount Kisco
State/Province
New York
ZIP/Postal Code
10549
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gino Bottino, MD
First Name & Middle Initial & Last Name & Degree
Gino Bottino, MD
Facility Name
Mid Dakota Clinic/Odyssey Research
City
Bismarck
State/Province
North Dakota
ZIP/Postal Code
58501
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bipinkumar R Amin, MD
First Name & Middle Initial & Last Name & Degree
Bipinkumar R Amin, MD
Facility Name
Summa Health System Hospitals
City
Akron
State/Province
Ohio
ZIP/Postal Code
44304
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
R. Douglas Trochelman, MD
First Name & Middle Initial & Last Name & Degree
R. Douglas Trochelman, MD
Facility Name
Nashat Y. Gabrail, MD, Inc.
City
Canton
State/Province
Ohio
ZIP/Postal Code
44718
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nashat Y Gabrail, MD
First Name & Middle Initial & Last Name & Degree
Nashat Y Gabrail, MD
Facility Name
Sambandam and Joseph Associates, Inc
City
Cranston
State/Province
Rhode Island
ZIP/Postal Code
02920
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Plakyil J Joseph, MD
First Name & Middle Initial & Last Name & Degree
Plakyil J Joseph, MD
Facility Name
Charleston Hematology Oncology, PA
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29403
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
George F Geils, Jr., MD
First Name & Middle Initial & Last Name & Degree
George F Geils, Jr., MD
Facility Name
South Carolina Oncology Associates
City
Columbia
State/Province
South Carolina
ZIP/Postal Code
29210
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Neal P Christiansen, MD
First Name & Middle Initial & Last Name & Degree
Neal P Christiansen, MD
Facility Name
The Family Cancer Center
City
Collierville
State/Province
Tennessee
ZIP/Postal Code
38017
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
David Gravenor, MD
First Name & Middle Initial & Last Name & Degree
David Gravenor, MD
Facility Name
C. Michael Jones, MD, PC
City
Germantown
State/Province
Tennessee
ZIP/Postal Code
38138
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
C. Michael Jones, MD, PC
First Name & Middle Initial & Last Name & Degree
C. Michael Jones, MD, PC
Facility Name
JPS Center for Cancer Care
City
Fort Worth
State/Province
Texas
ZIP/Postal Code
76104
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Debra M Prow, MD
First Name & Middle Initial & Last Name & Degree
Debra M Prow, MD
Facility Name
Cache Valley Cancer Treatment & Research Clinic, Inc.
City
Logan
State/Province
Utah
ZIP/Postal Code
84341
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ali Ben-Jacob, MD
First Name & Middle Initial & Last Name & Degree
Ali Ben-Jacob, MD
Facility Name
Cancer Outreach Associates, PC
City
Abingdon
State/Province
Virginia
ZIP/Postal Code
24211
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Forrest Swan, MD
First Name & Middle Initial & Last Name & Degree
Forest Swan, MD
Facility Name
Virginia Oncology Care, PC
City
Richlands
State/Province
Virginia
ZIP/Postal Code
24641
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Madhaven V Pillai, MD, PharmD,FACP
First Name & Middle Initial & Last Name & Degree
Madhaven V Pillai, MD, PharmD, FACP
12. IPD Sharing Statement
Links:
URL
http://www.pharmatech.com/
Description
Pharmatech - The Research Link website
Learn more about this trial
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
We'll reach out to this number within 24 hrs